4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-052285
Director sold 6,000 shares at an average $95.44 ($572,644)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McLoughlin Margaret · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-16 | Exercise or conversion : show line 1 in the form | +6,000 | $17.00 | $102,000 | 6,000 | D |
| 2021-08-16 | Sale : show line 2 in the form | −3,056 | $94.55 | $288,945 | 2,944 | D |
| 2021-08-16 | Sale : show line 3 in the form | −1,044 | $95.57 | $99,775 | 1,900 | D |
| 2021-08-16 | Sale : show line 4 in the form | −1,429 | $96.51 | $137,913 | 471 | D |
| 2021-08-16 | Sale : show line 5 in the form | −423 | $97.55 | $41,264 | 48 | D |
| 2021-08-16 | Sale : show line 6 in the form | −48 | $98.90 | $4,747 | 0 | D |
| Open-market sales · 6,000 sh · avg $95.44 · $572,644 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-16 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −6,000 | 85,911 | D |
Loading xslF345X03/doc4.xml…